LabCompass

Radosław Kaczmarek

Medicine · Indiana University

OpenAlex ORCID
Hemophilia Treatment and ResearchVirus-based gene therapy researchGlycosylation and Glycoproteins ResearchCAR-T cell therapy researchCarbohydrate Chemistry and Synthesis

Publications

93

Citations

1,455

Est. group size

—

Recurring co-author estimate

Active years

17

Publishing since 2010

Research summary
AI-generated

Radosław Kaczmarek studies treatments for hemophilia, an inherited bleeding disorder, with a strong focus on gene therapy that aims to provide long-lasting correction through a single treatment. A second strand of work examines glycobiology—how sugar molecules attach to proteins and lipids on cells—including blood group antigens and their role in allergies and transfusion. This combines clinical/translational research with basic biochemistry.

Gene therapy for hemophiliaHemophilia treatment and managementGlycosylation and glycoproteinsBlood group antigensAAV viral vectors and immunity

Publication activity has been steady and generally growing over the last decade, rising to a peak of 14 publications in 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.4/year recently
2017: 3 publications172018: 8 publications182019: 6 publications192020: 8 publications202021: 11 publications212022: 7 publications222023: 8 publications232024: 11 publications242025: 14 publications14252026: 2 publications26
Recent publications
Publishes in
  • Haemophilia×12
  • Blood×10
  • Molecular Therapy×9
  • Journal of Thrombosis and Haemostasis×5
  • Research and Practice in Thrombosis and Haemostasis×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile